Literature DB >> 25003864

Diversion remains the standard of care for modern management of war-related rectal injuries.

Mary T O'Donnell1, Lauren T Greer1, Jeffery Nelson1, Craig Shriver1, Amy Vertrees1.   

Abstract

INTRODUCTION: Management of rectal injuries in war-injured patients has evolved over time.
METHODS: Retrospective review of records of patients sustaining war-related rectal injuries admitted to Walter Reed Army Medical Center from Iraq and Afghanistan.
RESULTS: From 2003 to 2011, 67 males ages 18 to 40 sustained rectal injuries after secondary blast (64%), gunshot (33%), motor vehicle crash (1%), or helicopter crash (1%). Injuries were extraperitoneal (72%), intraperitoneal (25%), or both (3%). Rectal abbreviated injury score mean was 3 ± 1. Surgical management included end colostomy (66%), loop colostomy (28%), and no diversion (4%). Distal washout (24%) and drain placement (33%) were performed. Colostomy closure occurred in 79% of patients at an average of 237 days after injury.
CONCLUSIONS: Diversion is the preferred treatment of war-related rectal injuries. Loop colostomy is acceptable unless there is potential for evolving rectal injury. Routine use of presacral irrigation and drainage was not supported. Reprint &
Copyright © 2014 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Year:  2014        PMID: 25003864     DOI: 10.7205/MILMED-D-13-00533

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  3 in total

Review 1.  Historical Perspectives on Colorectal Trauma Management.

Authors:  Joshua A Tyler; David R Welling
Journal:  Clin Colon Rectal Surg       Date:  2017-12-19

Review 2.  Current Progress in EBV-Associated B-Cell Lymphomas.

Authors:  Yonggang Pei; Alexandria E Lewis; Erle S Robertson
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  Extraperitoneal Rectal Laceration Secondary to Blunt Trauma: Successful Transanal Endoscopic Repair with Hemoclips.

Authors:  Koo-Yong Hahn; Soon-Young Ko; Woo-Surng Lee; Yong-Hun Kim
Journal:  Chin Med J (Engl)       Date:  2017-10-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.